Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...

(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of Shield Across America, a historic coast-to-coast mobile ...

Please provide your email address to receive an email when new articles are posted on . Approximately 48% of patients underwent a follow-up colonoscopy within 6 months of abnormal stool-based ...

Strategic collaboration to enable streamlined and accelerated access to Shield blood-based colorectal cancer screening test across Quest’s vast network Physicians nationwide now have the ability to ...

While mammograms and smear tests are widely recognised, a crucial screening for bowel cancer often goes unnoticed, with new data revealing that nearly a third of eligible individuals in England are ...